{"groups":[{"description":"Phase I: Dose Escalation 1-5 mCi in 50mg of antibody","id":"FG000","title":"Phase I: Dose Escalation 1-5 mCi in 50mg of Antibody"},{"description":"Phase I: Dose Escalation 1-5 mCi in 20mg of antibody","id":"FG001","title":"Phase I: Dose Escalation 1-5 mCi in 20mg of Antibody"},{"description":"Phase I: Dose Escalation 1-5 mCi in 3-50mg of antibody","id":"FG002","title":"Phase I: Dose Escalation 1-5 mCi in 3-50mg of Antibody"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"1"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"1"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"The Phase I portion of the study has concluded. The Phase II portion will not open due to the study PI leaving the institution."}